Krka, d. d.
KRK
Rank in Stocks
#2131
Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved... Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved in the research, production, promotion, and sale of various pharmaceutical goods. Its market presence spans Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and numerous other international territories. The company's offerings are categorized into prescription medications, over-the-counter products, and veterinary health solutions. Its prescription drug pipeline targets a broad spectrum of medical conditions, including cardiovascular disorders, gastrointestinal issues, central nervous system ailments, pain management, anti-infective treatments, conditions affecting blood and blood-forming organs, urological problems, diabetes, and oncology. The array of non-prescription items includes products for oral and throat care, cough and cold remedies, analgesics, nasal preparations, vitamin and mineral supplements, products designed to enhance cerebral and peripheral circulation, digestive aids, and various general healthcare products. Furthermore, Krka supplies animal health products such as anti-infectives, antiparasitics, and other specialized formulations for both livestock and companion animals. Beyond its pharmaceutical operations, the company also provides health resort and tourist services. Krka, d. d. was established in 1954 and has its corporate headquarters in Novo Mesto, Slovenia.
Share Price
$318.12
Last synced: 2026-10-20
Market Cap
$9.63B
Change (1 day)
0.18%
Change (1 year)
29.20%
Country
SI
Trade Krka, d. d. (KRK)
Category
Healthcare
Revenue for Krka, d. d. (KRK)
Revenue in Jun 2026 TTM: $2.51B
According to Krka, d. d. latest financial reports the company's current revenue (TTM) is $2.51B. In 2023 the company made a revenue of $2.00B an increase over the revenue in the year 2022 that was $1.84B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Krka, d. d. from 2010 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $2.51B | 26.24% |
| 2024 | $1.99B | -0.50% |
| 2023 | $2.00B | 8.39% |
| 2022 | $1.84B | 3.47% |
| 2021 | $1.78B | -4.75% |
| 2020 | $1.87B | 11.56% |
| 2019 | $1.68B | 9.48% |
| 2018 | $1.53B | 0.72% |
| 2017 | $1.52B | 22.97% |
| 2016 | $1.24B | -2.28% |
| 2015 | $1.26B | -12.29% |
| 2014 | $1.44B | -12.69% |
| 2013 | $1.65B | 9.50% |
| 2012 | $1.51B | 8.31% |
| 2011 | $1.39B | 3.11% |
| 2010 | $1.35B | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 163.59% |
IN
|
